Multidisciplinary care

When it comes to cancer, there’s nothing simple about it. Multiple office visits to different specialists is the norm. This can translate into time lost waiting for appointments when treatments should be underway.

With our Multidisciplinary Clinics, Edward-Elmhurst Health brings together expert cancer professionals from a variety of specialties under one roof. This helps to speed up treatment and provide you with comprehensive, more convenient, care close to home.

We offer Multidisciplinary Clinics for the following:

Breast cancer

Breast Cancer Clinic (Edward)

Breast Health Multidisciplinary Clinic (Elmhurst)


GI/HPB (Hepatopancreaticobiliary) Clinic (Edward)

GI Clinic (Elmhurst)

Neurological cancer

Neurological Cancer Multidisciplinary Clinic (Edward)

Neurological Cancer Multidisciplinary Clinic (Elmhurst)

Thoracic cancer

Thoracic Cancer Multidisciplinary Clinic (Edward)

Thoracic Cancer Multidisciplinary Clinic (Elmhurst)

Cancer Center locations

Clinical trials

Edward-Elmhurst Health is committed to research and improving outcomes for patients.

View our clinical trials

Your care team

Our highly specialized teams pride themselves on giving patients the time and attention they deserve. Multidisciplinary teams include:

  • Medical and radiation oncologists
  • Surgeons
  • Radiologists
  • Pulmonologists
  • Gastroenterologists
  • Interventional radiologists
  • Pathologists
  • Genetic counselors
  • Physical therapists
  • Financial coordinators
  • Social workers
  • Dietitians

Learn more about your care team

Walter Payton Liver Outreach Clinic

The Walter Payton Liver Clinic is a dedicated medical and surgical unit at the University of Illinois Hospital & Health Sciences System, providing quality, innovative and multidisciplinary care to patients with liver disease.

Learn more

Related Clinical Trials

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating...
Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in high risk HER2-positive patients with residual invasive breast cancer following neoadjuvant therapy
Patients with HER2-positive primary breast cancer (BC) who do not achieve complete response after appropriate neoadjuvant therapy are at higher...
Testing the usual treatment of radiation therapy and hormonal therapy to hormonal therapy alone for low-risk, early stage breast cancer
This Phase III Trial evaluates whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive...
Testing the Use of the Immunotherapy Drugs Ipilimumab and Nivolumab Plus Radiation Therapy Compared to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed MGMT Unmethylated Glioblastoma
This phase II/III trial compares the usual treatment with radiation therapy and temozolomide to radiation therapy in combination with immunotherapy...